Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.5987
Revised: February 21, 2014
Accepted: April 1, 2014
Published online: May 28, 2014
Core tip: The pivotal role of radiofrequency ablation (RFA) has recently been established among the various treatment strategies for hepatocellular carcinoma (HCC), primarily due to its excellent local tumor control. RFA may be complementary to the other treatments with curative intent for HCC and its beneficial outcomes in patients have been demonstrated in several clinical studies.